Summary
The Mind Pump hosts tackle common protein myths before diving into a detailed segment on shilajit research. Sal presents multiple recent studies on shilajit, including a 2024 study showing it reduced amyloid beta-induced cytotoxicity in brain cells (neuroprotective effects), a 2022 randomized double-blind placebo-controlled trial demonstrating dose-dependent preservation of bone mineral density in postmenopausal women with osteopenia (60 participants, 250mg dose), and 2025 trials showing 250-500mg daily for eight weeks enhanced muscle adaptation. The hosts compare shilajit to other traditional supplements like tongkat ali and ashwagandha, noting what impresses them most is shilajit's breadth of benefits across multiple systems. They emphasize sourcing quality, recommending PrimaVie as the trusted standardized extract and warning that fake or low-quality shilajit is widespread.
Key Points
- A 2024 study found shilajit reduced amyloid beta-induced cytotoxicity in brain cells, suggesting neuroprotective effects
- A 2022 RCT with 60 postmenopausal women showed dose-dependent preservation of bone mineral density with shilajit
- 2025 trials showed 250-500mg daily for 8 weeks enhanced muscle adaptation and physical performance
- Shilajit improves sperm morphology and may help with male fertility
- The hosts note shilajit stands out for its breadth of benefits across multiple body systems
- PrimaVie is recommended as the gold-standard source for quality shilajit
- Fake and low-quality shilajit products are widespread -- buyer beware
- 250mg is considered an efficacious dose, with studies supporting up to 500mg daily
Key Moments
Shilajit neuroprotective effects from 2024 study
Sal presents a 2024 study showing shilajit reduced amyloid beta-induced cytotoxicity in brain cells, suggesting neuroprotective benefits and potential relevance to Alzheimer's prevention.
"They found that Shilajit reduced amyloid beta-induced cytotoxicity in certain cells in the brain. In other words, probably good for brain health. So neuro, there's some neuroprotective effects."
Bone density RCT in postmenopausal women
A 2022 randomized double-blind placebo-controlled trial of 60 postmenopausal women with osteopenia found dose-dependent preservation of bone mineral density in the lumbar spine with shilajit supplementation.
"there was a 2022 randomized double-blind placebo-controlled trial that examined Shalajit's effects on bone health in postmenopausal women with osteopenia. So 60 participants got 250 or There was a dose-dependent preservation of bone mineral density in the lumbar spine, along with reduced oxidative stress and inflammation."
Quality sourcing and PrimaVie recommendation
The hosts warn about fake and low-quality shilajit products flooding the market and recommend PrimaVie as the trusted standardized source used in clinical studies.
"The thing with Shilajit, though, is you can get crappy Shilajit or you can get fake Shilajit."
